Oral Administration of the Probiotic <i>Lacticaseibacillus rhamnosus</i> CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study.

Microorganisms · 2025 · PMC12734845 · PMID 41471856

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Moreover, seven days after the end of the treatment, both itching and vulvovaginal erythema/edema were characterized by an increasing trend, reaching values similar to those observed at baseline [ 32 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Oral Administration of the Probiotic &lt;i&gt;Lacticaseibacillus rhamnosus&lt;/i&gt; CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study.

The sentences

Oral Administration of the Probiotic <i>Lacticaseibacillus rhamnosus</i> CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study.